Skip to main content

Published locations for HER2+/HR− BC: Responders to deescalated trastuzumab+pertuzumab can safely omit paclitaxel

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. HER2+/HR− BC: Responders to deescalated trastuzumab+pertuzumab can safely omit paclitaxel

User login

  • Reset your password
  • /content/her2/hr-bc-responders-deescalated-trastuzumabpertuzumab-can-safely-omit-paclitaxel
  • /hematology-oncology/article/254749/breast-cancer/her2/hr-bc-responders-deescalated
  • /breast-cancer-icymi/article/254749/breast-cancer/her2/hr-bc-responders-deescalated